Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Global Forecast 2024-2030
The Allergy Drugs Market size was estimated at USD 29.71 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 8.48% to reach USD 52.54 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.
Market Segmentation & Coverage
This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Drug Allergy
Anti-allergy Drugs
Antihistamines
Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
Hospital Pharmacies
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Allergy Drugs Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Drugs Market?
- What are the technology trends and regulatory frameworks in the Allergy Drugs Market?
- What is the market share of the leading vendors in the Allergy Drugs Market?
- Which modes and strategic moves are suitable for entering the Allergy Drugs Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Allergy Drugs Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of allergy globally
- 5.1.1.2. Increasing development of allergy-specific drugs
- 5.1.1.3. Rise in prevalence towards over the counter drugs
- 5.1.2. Restraints
- 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
- 5.1.3.2. Rising consumer awareness on food allergies
- 5.1.4. Challenges
- 5.1.4.1. Availability of alternative drugs for allergy
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Allergy Drugs Market, by Type
- 6.1. Introduction
- 6.2. Drug Allergy
- 6.3. Food Allergy
- 6.4. Inhaled Allergy
- 7. Allergy Drugs Market, by Treatment
- 7.1. Introduction
- 7.2. Anti-allergy Drugs
- 7.3.1. Antihistamines
- 7.3.2. Corticosteroids
- 7.3.3. Leukotriene Inhibitors
- 7.3. Immunotherapy
- 7.4.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
- 8. Allergy Drugs Market, by Distribution Channels
- 8.1. Introduction
- 8.2. Hospital Pharmacies
- 8.3. Online Pharmacies
- 8.4. Retail Pharmacies & Drug Stores
- 9. Americas Allergy Drugs Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Allergy Drugs Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Allergy Drugs Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Allergy Therapeutics PLC
- 13.1.2. Astra Biotech GmbH
- 13.1.3. AstraZeneca PLC
- 13.1.4. Bayer AG
- 13.1.5. GlaxoSmithKline PLC
- 13.1.6. HAL Allergy B.V.
- 13.1.7. Hikma Pharmaceuticals PLC
- 13.1.8. Johnson & Johnson Services, Inc.
- 13.1.9. LETI Pharma, S.L.U.
- 13.1.10. Lupin Limited
- 13.1.11. Mylan N.V. by Viatris Inc.
- 13.1.12. Novartis AG
- 13.1.13. Sanofi SA
- 13.1.14. Teva Pharmaceutical Industries Ltd.
- 13.1.15. XOLAIR by F. Hoffmann-La Roche AG
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ALLERGY DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. ALLERGY DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ALLERGY DRUGS MARKET DYNAMICS
- FIGURE 7. ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 10. ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
- FIGURE 12. ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook